RecruitingNCT02964637
Diagnosing Frontotemporal Lobar Degeneration
Multimodal Assessment for Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration
Sponsor
University Health Network, Toronto
Enrollment
100 participants
Start Date
Aug 1, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
To establish diagnostic tools to make an accurate clinical and pathological diagnosis of patients with clinical FTLD syndromes
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Observational Study for people with amyotrophic lateral sclerosis and/or frontotemporal dementia, behavioral variant frontotemporal dementia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERObservational Study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02964637
Related Trials
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT032251441 location
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
NCT075702121 location
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
NCT026057851 location
Intervention for Communication Quality of Life in Primary Progressive Aphasia
NCT072196801 location
The Swedish BioFINDER 2 Study
NCT031749382 locations